IPG Photonics
IPGP
80.89
-2.80
-3.35%
IPG Photonics
US · IPGP
#2369 by market cap
Listed 1970
80.89
-2.80
-3.35%
Live - 5344 symbols - heartbeat 113s ago
· 2026-10-08 08:02
Pre-market
78.80
-2.58%
After-hours
80.89
0.00%
- Market cap
- 3.44B
- P/E (TTM)i
- 124.45
- P/Bi
- 1.62
- EPSi
- 0.73
- Div yieldi
- 0.00%
- 52W posi
- 13%
Reader sentiment
Are you bullish or bearish on IPGP?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 9.53, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +2.73% YoY
Margins
- Gross margin
- 38.00%
- Operating margin
- 2.30%
- Net margin
- 3.10%
Key ratios & quality
- Altman Z-Scorei
- 9.53
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.46B | 1.31B | 1.20B | 1.46B | 1.43B | 1.29B | 977.13M | 1.00B |
| Gross profit | 800.27M | 606.21M | 539.00M | 696.40M | 555.41M | 541.70M | 338.16M | 381.46M |
| Selling & admin expenses | 160.24M | 185.34M | 180.59M | 204.06M | 207.90M | 211.43M | 213.90M | 241.00M |
| Research & development | 122.77M | 130.00M | 126.90M | 139.57M | 116.11M | 98.70M | 109.78M | 117.40M |
| Operating profit | 517.26M | 290.87M | 231.51M | 352.76M | 231.40M | 231.57M | 14.48M | 23.06M |
| Pretax profit | 534.40M | 248.38M | 205.69M | 366.48M | 183.35M | 274.88M | -161.89M | 45.10M |
| Tax | 130.23M | 68.12M | 45.35M | 88.62M | 72.59M | 56.00M | 19.64M | 14.00M |
| Net profit | 404.17M | 180.26M | 160.34M | 277.87M | 110.76M | 218.88M | -181.53M | 31.10M |
| Basic EPS | 8 | 3 | 3 | 5 | 2 | 5 | -4 | 1 |
| Diluted EPS | 7.38 | 3.35 | 2.97 | 5.16 | 2.16 | 4.63 | -4.09 | 0.73 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 227.79M | 250.72M | 250.79M | 274.47M | 265.50M | 278.58M |
| Gross profit | 89.81M | 93.57M | 99.01M | 99.07M | 99.50M | 112.52M |
| Selling & admin expenses | 57.24M | 60.43M | 58.86M | 64.47M | 60.63M | 60.36M |
| Research & development | 28.34M | 29.94M | 30.36M | 28.77M | 33.31M | 31.00M |
| Operating profit | 4.24M | 3.20M | 9.78M | 5.84M | 5.56M | 21.16M |
| Pretax profit | 10.62M | 8.27M | 15.65M | 10.56M | 1.02M | 12.54M |
| Tax | 6.86M | 1.67M | 8.19M | -2.71M | -565.00K | 7.30M |
| Net profit | 3.76M | 6.61M | 7.46M | 13.27M | 1.58M | 5.24M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.09 | 0.16 | 0.18 | 0.31 | 0.04 | 0.12 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.81B | 1.90B | 2.15B | 2.35B | 1.99B | 1.91B | 1.43B | 1.42B |
| Cash & ST investments | 1.04B | 1.18B | 1.39B | 1.51B | 1.18B | 1.18B | 930.19M | 839.33M |
| Inventory | 403.58M | 380.79M | 364.99M | 460.75M | 509.36M | 453.87M | 284.78M | 313.42M |
| Total assets | 2.57B | 2.73B | 2.94B | 3.17B | 2.74B | 2.70B | 2.29B | 2.42B |
| Total current liabilities | 245.77M | 191.90M | 214.58M | 313.43M | 274.65M | 214.86M | 205.02M | 234.04M |
| Short-term debt | 3.67M | 9.04M | 9.59M | 23.58M | 21.27M | 4.60M | 4.84M | 5.07M |
| Long-term debt | 41.71M | 37.97M | 34.16M | 16.03M | -- | -- | -- | -- |
| Total liabilities | 368,215,000.00 | 327,993,000.00 | 341,589,000.00 | 423,319,000.00 | 357,920,000.00 | 283,513,000.00 | 264,793,000.00 | 296,150,000.00 |
| Total equity | 2.21B | 2.40B | 2.59B | 2.75B | 2.39B | 2.42B | 2.02B | 2.13B |
| Retained earnings | 1.85B | 2.03B | 2.19B | 2.47B | 2.58B | 2.80B | 2.61B | 2.64B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.44B | 1.47B | 1.43B | 1.42B | 1.43B | 1.48B |
| Cash & ST investments | 926.88M | 899.60M | 870.39M | 839.33M | 812.91M | 871.32M |
| Inventory | 287.62M | 303.84M | 323.93M | 313.42M | 319.01M | 330.80M |
| Total assets | 2.32B | 2.38B | 2.38B | 2.42B | 2.42B | 2.42B |
| Total current liabilities | 197.03M | 216.95M | 213.38M | 234.04M | 247.18M | 239.32M |
| Short-term debt | 4.32M | 4.77M | 4.90M | 5.07M | 5.00M | 5.19M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 256,906,000.00 | 274,896,000.00 | 276,151,000.00 | 296,150,000.00 | 305,847,000.00 | 297,389,000.00 |
| Total equity | 2.06B | 2.10B | 2.10B | 2.13B | 2.12B | 2.13B |
| Retained earnings | 2.62B | 2.62B | 2.63B | 2.64B | 2.65B | 2.65B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 393.30M | 323.52M | 285.34M | 389.70M | 212.65M | 295.99M | 247.90M | 75.34M |
| Depreciation & amortization | 80.27M | 96.27M | 94.55M | 96.33M | 90.56M | 69.62M | 61.44M | 66.85M |
| Free cash flow | 232.96M | 189.99M | 197.64M | 266.59M | 102.51M | 185.50M | 149.37M | -3.45M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -176.07M | -40.73M | -37.88M | -134.89M | -499.51M | -223.50M | -343.82M | -53.13M |
| Ending cash balance | 544.36M | 682.98M | 878.55M | 709.11M | 698.21M | 514.67M | 620.04M | 403.79M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 13.45M | -2.22M | 35.31M | 28.81M | -5.46M | 37.79M |
| Depreciation & amortization | 15.34M | 15.83M | 15.63M | 20.06M | 15.89M | 15.52M |
| Free cash flow | -11.37M | -17.57M | 14.58M | 10.92M | -21.77M | 17.08M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 105.00K | -30.31M | -16.40M | -6.53M | 0 | 0 |
| Ending cash balance | 363.05M | 359.18M | 346.03M | 403.79M | 480.76M | 399.78M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 19.11 | 7.82 | 6.39 | 10.43 | 4.28 | 9.12 | -8.18 | 1.50 |
| ROA %i | 16.35 | 6.80 | 5.63 | 9.12 | 3.72 | 8.04 | -7.28 | 1.32 |
| ROIC %i | 18.70 | 7.23 | 6.08 | 10.27 | 4.22 | 9.01 | -8.11 | 1.49 |
| 5-year avg ROE %i | 19.67 | 17.17 | 14.25 | 12.64 | 9.61 | 7.61 | 4.41 | 3.43 |
| EBIT margin %i | 35.43 | 22.13 | 19.28 | 24.15 | 16.19 | 17.99 | 1.48 | 2.30 |
| FCF / sales %i | 15.96 | 14.45 | 16.46 | 18.25 | 7.17 | 14.41 | 15.29 | -- |
| Current ratioi | 7.35 | 9.88 | 10.01 | 7.49 | 7.23 | 8.91 | 6.98 | 6.08 |
| Quick ratioi | 5.29 | 7.41 | 7.71 | 5.67 | 5.06 | 6.50 | 5.37 | 4.36 |
| Debt / assetsi | 1.76 | 1.72 | 1.49 | 1.83 | 1.39 | 0.68 | 0.78 | 0.71 |
| LT debt / equityi | 1.89 | 1.58 | 1.32 | 1.26 | 0.70 | 0.57 | 0.65 | 0.57 |
| Interest coveragei | -- | -- | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | 17.44 | 9.32 | -5.19 | 0.02 | 2.83 | 2.35 | -12.55 | -11.12 |
| Net income CAGR (3Y) %i | 18.61 | -11.58 | -22.86 | -11.67 | -15.20 | 11.11 | -- | -34.35 |
| FCF CAGR (3Y) %i | 6.41 | 3.64 | -10.84 | 4.60 | -18.59 | -2.09 | -17.56 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -9.17 | -9.89 | 1.22 | 1.50 | 1.39 | 1.30 |
| ROA %i | -8.21 | -8.84 | 1.08 | 1.32 | 1.22 | 1.15 |
| ROIC %i | -9.10 | -9.81 | 1.21 | 1.49 | 1.37 | 1.29 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 0.49 | -0.71 | 3.22 | 2.30 | 2.34 | 3.96 |
| FCF / sales %i | 11.70 | 6.83 | 3.76 | -- | -- | 1.94 |
| Current ratioi | 7.33 | 6.79 | 6.72 | 6.08 | 5.80 | 6.18 |
| Quick ratioi | 5.60 | 5.07 | 4.86 | 4.36 | 4.07 | 4.40 |
| Debt / assetsi | 0.70 | 0.71 | 0.73 | 0.71 | 0.67 | 0.67 |
| LT debt / equityi | 0.58 | 0.57 | 0.59 | 0.57 | 0.53 | 0.52 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Lasers and Components is the largest reported line at 78.91% of revenue, across 2 reported segments.
- The next-largest line, Systems, is a distant second at 21.09% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Lasers and Components78.91%
Systems21.09%
Quote time 2026-10-08 08:02:15 · For reference only, not investment advice and not tailored to your situation.